Position in LLY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$154,078,790
+$46,102,391 QoQ
Shares Held
128,460
+9.4% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.60%
of 13F equity value
Holder Rank
#305
of 4,605 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NEOS Investment Management LLC holds $692,824,213 across 9 Drug Manufacturers - General names. LLY ranks #1 (22.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
128,460 | $154,078,790 | |
| 2 | AMGN |
Amgen Inc
|
409,827 | $148,406,553 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
950,430 | $120,077,326 | |
| 4 | JNJ |
Johnson & Johnson
|
392,087 | $99,578,335 | |
| 5 | ABBV |
AbbVie Inc.
|
286,410 | $72,072,212 | |
| 6 | MRK |
Merck & Co., Inc.
|
404,459 | $51,972,981 | |
| 7 | PFE |
Pfizer Inc
|
930,777 | $22,413,110 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
331,429 | $19,096,938 |
All Filings in LLY
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $154,078,790 | 128,460 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $107,976,399 | 117,395 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $125,286,205 | 116,580 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $78,604,260 | 103,020 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $58,456,174 | 74,989 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $54,134,270 | 65,545 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $39,016,880 | 50,540 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $34,690,752 | 39,157 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $30,998,399 | 34,238 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $18,877,198 | 24,265 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $7,387,344 | 12,673 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,107,969 | 7,648 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||